Angle up 25% on “sensational” data results

Angle is a specialist medtech company which has developed a technology for harvesting circulating tumour cells in blood – you can read more about Angle and its technology in AimZine’s 10 Bagger Quest article featuring the Company at http://www.investorschampion.com/aimzine/entry/the-ten-bagger-quest. Angle’s announcement yesterday reported that the Medical University of Vienna has reported highly convincing patient data in support of the use of ANGLE’s Parsortix system in the detection of ovarian cancer. In the RNS the Principal Investigator at the Medical university describes the results with ANGLE’s Parsortix system as “sensational” and offering “unprecedented sensitivity and specificity”. In the results achieved to…